Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124879282 | 12487928 | 2 | F | 20160620 | 20160622 | 20160705 | EXP | FR-AUROBINDO-AUR-APL-2016-07813 | AUROBINDO | 41.00 | YR | F | Y | 0.00000 | 20160704 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124879282 | 12487928 | 1 | PS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 13500 MG, UNK | U | 90555 | 13500 | MG | |||||||
124879282 | 12487928 | 2 | SS | ALIMEMAZINE | TRIMEPRAZINE | 1 | Oral | 1200 MG, UNK | U | 0 | 1200 | MG | |||||||
124879282 | 12487928 | 3 | SS | OXAZEPAM. | OXAZEPAM | 1 | Oral | 11700 MG, UNK | U | 0 | 11700 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124879282 | 12487928 | 1 | Product used for unknown indication |
124879282 | 12487928 | 2 | Product used for unknown indication |
124879282 | 12487928 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124879282 | 12487928 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124879282 | 12487928 | Overdose | |
124879282 | 12487928 | Serotonin syndrome | |
124879282 | 12487928 | Shock | |
124879282 | 12487928 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |